Briceño DF; Correa A; Valencia CA; Torres JA; Pacheco R; Montealegre MC; Ospina D; Villegas MV. 2010. Actualización de la resistencia a antimicrobianos de bacilos Gram negativos aislados en hospitales nivel III de Colombia: años 2006, 2007 y 2008. y Grupo de Resistencia Bacteriana Nosocomial de Colombia. Biomédica. 30(3):00 - 00

Lopez JA; Correa A; Navon-Venezia S; Correa AL; Torres JA; Briceño DF; Montealegre MC; Quinn JP, Carmeli Y; Villegas MV. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect. 2010 Mar 6. [Epub ahead of print] Accepted Article”; doi: 10.1111/j.1469-0691.2010.03209.x

Cuzon G, Naas T; Truong H; Villegas MV; Wisell KT; Carmeli Y; Gales AC; Venezia SN; Quinn JP; Nordmann P. 2010.  Worldwide diversity of Klebsiella pneumoniae that produce β-Lactamase blaKPC-2 Gene. Emerg Infect Dis. 16(9):1349-1356

Briceño DF; Quinn J; Villegas MV. 2010. Treatment options for multidrug-resistant nonfermenters. Expert Rev. Anti Infect. Ther. 8(3):303–315

Akpaka PE; Swanston WH; Ihemere HM; Correa A; Torres JA; Tafur DA; Montealegre MC; Quinn JP; Villegas MV. 2009. Emergence of KPC-producing pseudomonas aeruginosa in Trinidad and Tobago. J Clin Microbiol. 47(8):2670-2671

Cortés JA; Cuervo SI; Urdaneta AM; Potdenvin G; Arroyo P; Bermúdez D; Correa A; Villegas MV. 2009. Identifying and Controlling a Multiresistant Pseudomonas aeruginosa Outbreak in a Latin-American Cancer Centre and Its Associated Risk Factors. Braz J Infect Dis. 13(2):99 -103

Tafur JD, Torres JA, Villegas MV. 2008. Mecanismos de Resistencia a Antibióticos en Bacterias Gram negativas. Infectio. 12(3), 223-233

Kattan J; Villegas MV; Quinn JP. 2008. New developments in carbapenems. Clin Microbiol Infect. 14: 1102–1111

Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. 2008. Genetic structures at the origin of Acquisition of the β-lactamase blaKPC Gene. Ant Agents Chem. 52(4):1257-1263

Arias CA, Vallejo M, Reyes J, Panesso D, Moreno J, Castañeda E, Villegas MV, Murray BE, Quinn JP. 2008. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase. J Clin Microbiol. 46(3):892-6

Villegas MV, Kattan JN, Quinteros MG, Casellas JM. 2008. Prevalence of extended-spectrum beta-lactamases in South America. Clin Microbiol Infect. 14(Suppl 1):154-8

Torres JS; Villegas MV; Quinn JP. 2007. Current concepts in antibiotic-resistant gram-negative bacteria. Expert Rev Anti Infect Ther. 5(5):833-43

Toh SM; Xiong L;  Arias CA; Villegas MV; Lolans K; Quinn JP; Mankin AS. 2007. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Molecular Microbiol. 64(6):1506-1514

Villegas MV; Correa A; Kattan JN; Lolans K; Gúzman AM; Woodford N; Livermore D; Quinn JP. 2007. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian Hospitals. Ant Agents Chemother. 51(6):2001-2004

Villegas MV; Lolans K; Correa A; Kattan JN; López JA; Quinn JP and the Colombian Nosocomial Resistance Study Group. 2007. First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing {beta}-Lactamase. Ant Agents Chemother. 51(4):1553-1555

Miranda MC; Pérez  F; Correa A; Zuluaga T; Olivera MR; Reyes SL; Villegas MV; Grupo de Resistencia Bacteriana Nosocomial de Colombia. 2006. Resistencia a antimicrobianos de bacilos Gram negativos aislados en unidades de cuidado intensivo en hospitales de Colombia, WHONET 2003, 2004 y 2005. Biomédica. 26(3):424-433

Súarez CJ; Kattan JN; Guzmán AM; Villegas MV. 2006. Mecanismos de resistencia a carbapenems en P. aeruginosa, Acinobacter y Enterobacteriaceae y estrategias para su prevención y control. Infectio. 10(2):85-93

Villegas MV, Lolans K, Olivera MR, Suarez CJ, Correa A, Queenan AM, Quinn JP and the Colombian Nosocomial Resistance Study Group. 2006.  First detection of metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia. Antimicrob Agents Chemother. 50(1):226-229

Olivera MR; Correa A; Reyes SL; Miranda MC; Villegas MV; Grupo de Estudio de INVANZ. 2005. Actividad in vitro de ertapenem frente a enterobacterias provenientes de la comunidad en siete ciudades de Colombia. Infectio. 9(4):180-187

Súarez CJ; Lolans K; Villegas MV; Quinn JP. 2005. Mechanisms of resistance to β-lactams in some common Gram-negative bacteria causing nosocomial infections. Expert Review of Anti-infective Therapy. 3(6):915-922. Review

Villegas MV; Quinn JP. 2004. An update on  antibiotic resistant gram negative bacteria. Infect Med. 21(12):595-599.

Villegas MV, Correa A, Perez F, Miranda MC, Zuluaga T, Quinn JP. Colombian Nosocomial Resistance Study Group. 2004. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis. 49(3):217-22

Villegas MV; Correa A; Pérez F; Zuluaga T; Radice M; Gutkind G; Casellas JM; Ayala J; Lolans K; Quinn JP. The Colombian Nosocomial Resistance Study Group. 2004. CTX-M-12 beta-Lactamase in a Klebsiella pneumoniae Clinical Isolate in Colombia. Antimicrob Agents Chemother. 48(2): 629-631

Villegas MV, Hartstein AI. 2003. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol.  24(4): 284-95. Review